Articles

Home /Articles / FDA Federal Register Notices

No article fund in this category

Top News

FDA Accepts Replimune's Resubmitted BLA for Advanced Melanoma
FDA WEBVIEW CLOSED JULY 4TH WEEK
FDA Declines to Approve Sobi Gout Therapy
EC Opens Antitrust Probe into Sanofi's Flu Vaccine Marketing
OAI Inspections at U.S. Drug Sites Surpassed India in 2025: Analysis
Capricor's Duchenne Cell Therapy Set for Advisory Committee Review
Dr. Reddy's Gets 7-Item FDA Form 483 After Biologics Inspection
Lantheus Gets Complete Response Letter for Tumor Imaging Agent

Prev

FDA Webview Free Daily e-Newsletter

Free Sign-Up

Dickinson's FDA Webview is the interactive Web site that watches the U.S. Food and Drug Administration all day long. From the leading publisher of FDA-content business newsletters since 1984, you can monitor regulatory, legal, policy and scientific news affecting all FDA-regulated healthcare products and their marketing activities.